Roche Holding AG’s (RHHBY) breast cancer drug Herceptin increases the risk of cardiac toxicity, but the majority of this heart damage can be reversed with treatment, a new study, published Monday, showed.>>> Discuss This Story
Roche Holding AG’s (RHHBY) breast cancer drug Herceptin increases the risk of cardiac toxicity, but the majority of this heart damage can be reversed with treatment, a new study, published Monday, showed.>>> Discuss This Story
